Talkdesk AI Agents for Healthcare transforms patient and member experience with agentic artificial intelligence

Talkdesk unlocks the transformative value for providers and payers by applying the next generation of automation to patient and member access, service, and support workflows PALO ALTO, Calif. & LAS VEGAS–(BUSINESS WIRE)–#AIAgents—Talkdesk®, Inc., a global provider of artificial intelligence (AI)-powered customer experience (CX) technology that serves enterprises of all sizes, is helping healthcare organizations effortlessly … [Read more…]

Global Pharma Handbook 2025: Updated Regulatory Guide to the World Pharmaceutical Industry – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Pharma Handbook 2025” has been added to ResearchAndMarkets.com’s offering. The fully revised and expanded Global Pharma Handbook provides pharmaceutical industry decision-makers with a unique source of accurate, up-to-date information and analysis on prescription drug business and regulatory environments throughout the world. Coverage of over 70 individual countries (cumulatively representing more than 97% … [Read more…]

Latent TB Testing Market Research 2025: Analysis 2020-2023, 2024 Estimates and Forecasts 2025-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)” report has been added to ResearchAndMarkets.com’s offering. The Global Latent TB Testing market showcased growth at a CAGR of 10.47% during … [Read more…]

Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera

− Study met the primary endpoint, with a significantly higher proportion of clinical responders on rusfertide compared to placebo − All four key secondary endpoints were met, including EU primary endpoint and patient-reported outcomes − Rusfertide was generally well tolerated; no new safety findings were observed in the study NEWARK, Calif. & OSAKA, Japan & … [Read more…]

QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing

QIAGEN files lawsuit against bioMérieux with German Unified Patent Court to protect key innovations in its QuantiFERON technology QuantiFERON-TB Gold Plus plays a critical role in fighting the spread of TB worldwide VENLO, The Netherlands–(BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: … [Read more…]

Ansell Expands Portfolio to Include Kimtech, KleenGuard and RightCycle Brands in North America and Europe

MELBOURNE, Australia–(BUSINESS WIRE)–Ansell Limited (ASX: ANN), a global leader in protection solutions, announced today that its sales organisation will begin accepting Kimtech™ and KleenGuard™ orders and managing customer inquiries across North America and Europe. This marks the first significant commercial milestone following the strategic acquisition of Kimberly-Clark’s Personal Protective Equipment (KCPPE) business last year and … [Read more…]

BostonGene to Showcase Multi-Modal AI-Powered Platform at the 22nd Annual Meeting of the Japanese Society of Medical Oncology

Advancing Precision Oncology with AI-Driven Multiomics for Optimized Therapy Selection and Improved Patient Outcomes WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced its participation in the 22nd Annual Meeting of the Japanese Society of Medical Oncology (JSMO2025) from March 6–8, 2025, in Kobe, Japan. This premier conference is … [Read more…]

Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies

– First-ever head-to-head trial comparing Xolair and oral immunotherapy (OIT) – – Results were featured as late-breakers at the 2025 AAAAI Annual Meeting – – Xolair is the only U.S. FDA-approved medicine to reduce allergic reactions in children and adults with one or more food allergies – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of … [Read more…]

Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps

TEZSPIRE significantly reduced nasal congestion, polyp size and nearly eliminated the need for surgery in patients with chronic rhinosinusitis with nasal polyps WAYPOINT data published in New England Journal of Medicine and highlighted as late-breaking oral presentation at AAAAI/WAO 2025 WILMINGTON, Del.–(BUSINESS WIRE)–Full results from the positive Phase III WAYPOINT trial showed AstraZeneca and Amgen’s … [Read more…]

Prime Healthcare Completes Historic Acquisition of Ascension Hospitals and Care Sites in Illinois

ONTARIO, Calif.–(BUSINESS WIRE)–#InPrimeHealth–Prime Healthcare announced today that it has successfully completed the historic acquisition of eight Ascension Illinois hospitals, four senior living and post-acute care facilities, and physician practices, signaling a new era of service excellence and award-winning healthcare in the Greater Chicago area. After an extensive review process, the Illinois Health Facilities and Services … [Read more…]